Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Role of pharmacogenetics in irinotecan therapy - de Jong_2006_Cancer.Lett_234_90 |
Author(s) : de Jong FA , de Jonge MJ , Verweij J , Mathijssen RH |
Ref : Cancer Letters , 234 :90 , 2006 |
Abstract : de Jong_2006_Cancer.Lett_234_90 |
ESTHER : de Jong_2006_Cancer.Lett_234_90 |
PubMedSearch : de Jong_2006_Cancer.Lett_234_90 |
PubMedID: 16343744 |
Title : Irinotecan pathway genotype analysis to predict pharmacokinetics - Mathijssen_2003_Clin.Cancer.Res_9_3246 |
Author(s) : Mathijssen RH , Marsh S , Karlsson MO , Xie R , Baker SD , Verweij J , Sparreboom A , McLeod HL |
Ref : Clin Cancer Research , 9 :3246 , 2003 |
Abstract : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
ESTHER : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
PubMedSearch : Mathijssen_2003_Clin.Cancer.Res_9_3246 |
PubMedID: 12960109 |
Gene_locus related to this paper: human-CES2 |